Medical School

Division of Pediatric Hematology/Oncology

Department of Pediatrics

Joseph Neglia, MD, MPH

MEDPEDS2 - Image - 180x222 - Joseph Neglia

Academic Title

Department Head, Pediatrics

Clinical Title

Pediatric Hematologist Oncologist


Medical School
Loma Linda University School of Medicine, Loma Linda, CA
Baylor College of Medicine, Houston, Texas
Pediatric Hematology-Oncolgy, University of Minnesota School of Medicine
M.P.H., Epidemiology, University of Minnesota School of Public Health

Contact Info


(612) 624-3113

(612) 626-6601

Office Address

Pediatrics Department Head Office
6th Floor East Building
2450 Riverside Ave
Minneapolis, MN 55454

Mailing Address

6th Floor East Building
8952A (Campus Delivery Code)
2450 Riverside Ave
Minneapolis, MN 55454

Bio Statement

Ruben-Bentson Chair and Professor of Pediatrics
Minnesota American Legion and Auxiliary Chair in Children's Health
University of Minnesota Medical School
University of Minnesota Amplatz Children's Hospital

Dr. Joseph Neglia is currently a Professor in the Division of Pediatric Hematology/Oncology at the University of Minnesota in Minneapolis. He has been at the University of Minnesota since 1984 when he came to pursue a fellowship in Pediatric Hematology/Oncology and Blood and Marrow Transplantation.

Dr. Neglia received his M.D. degree in 1981 from Loma Linda University School of Medicine and was a pediatric intern, resident and chief resident at the Baylor College of Medicine in Houston, Texas. During his fellowship at the University of Minnesota, Dr. Neglia received a Master's degree in Public Health in Epidemiology. Following his fellowship, he was an Instructor in the Department of Pediatrics (1987), promoted to Assistant Professor in 1988, Associate Professor in 1992 and Full Professor in 2002. He has a joint appointment in the Department of Epidemiology in the School of Public Health.

Dr. Neglia's area of research involves the long-term effects of cancer therapy in cancer survivors and the occurrence of second malignancies following childhood cancer. He is nationally and internationally recognized for his contributions to the field of childhood cancer long-term effects. He currently is Principal Investigator at the Masonic Cancer Center, University of Minnesota for the Children's Oncology Group (COG) and the vice-chair of the Voting Body of the COG. Dr. Neglia is currently the principal investigator of an American Cancer Society Grant investigation neuro-behavioral outcomes of children recently treated for leukemia.

Dr. Neglia has been involved in numerous service activities both within and outside of the University of Minnesota. He is an active member of the Children's Oncology Group, the American Society of Pediatric Hematology/Oncology, and the Masonic Cancer Center. University of Minnesota. He regularly reviews manuscripts for numerous journals including the New England Journal of Medicine, the Journal of the National Cancer Institute, and Cancer among others. At the University level he has been elected as an alternate member of the University Senate, developed and directed the original Cancer Center Database.

Research Interests

  1. Long-term effects of cancer therapy.
  2. Occurrence of second malignancies following childhood cancer.

  • 1981 Alpha Omega Alpha
  • 1981 Vice-President, Loma Linda University School of Medicine, Class of 1981
  • 1983 Chief Pediatric Resident, Jefferson Davis County Hospital, Houston, TX
  • 1984-85 Clinical Fellow, American Cancer Society
  • 1987 American Association for Cancer Research - Upjohn Travel Award
  • 1988 Pi Chapter, Delta Omega Public Health Honor Society

  • ©2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on March 24, 2014